エピソード

  • Timely and Optimal Glycemic Control with Empagliflozin and Linagliptin Combination in T2DM Management | Dr. Sagnik Mukhopadhyay & Dr. Sourav Dey

    Timely and Optimal Glycemic Control with Empagliflozin and Linagliptin Combination in T2DM Management | Dr. Sagnik Mukhopadhyay & Dr. Sourav Dey
    2023/03/17

    Listen to the Experts Discuss the Relevance of Timely and Optimal Glycemic Control with Empagliflozin and Linagliptin Combination in Management of T2DM.
    続きを読む 一部表示
    31 分
  • Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM management | Dr. D. C. Sharma & Dr. Vinod Bokadia

    Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM management | Dr. D. C. Sharma & Dr. Vinod Bokadia
    2023/03/16

    Listen to the Experts Discuss the Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM management.
    続きを読む 一部表示
    23 分
  • Empowering glycemic control+organ protection with empagliflozin + linagliptin combination | Dr. sanjeet Jaiswal & Dr. Smit Shrivastava

    Empowering glycemic control+organ protection with empagliflozin + linagliptin combination | Dr. sanjeet Jaiswal & Dr. Smit Shrivastava
    2023/03/13

    Listen to the Experts Discuss the Empowering glycemic control+organ protection with empagliflozin + linagliptin combination.
    続きを読む 一部表示
    18 分
  • Two Peas in a Pod - Empa Lina Cross Talk | Dr. Amitabh Sur & Dr. Soumik Chaudhuri

    Two Peas in a Pod - Empa Lina Cross Talk | Dr. Amitabh Sur & Dr. Soumik Chaudhuri
    2023/03/13

    Listen to the Experts Discuss the Two Peas in a Pod - Empa Lina Cross Talk.
    続きを読む 一部表示
    19 分
  • Rationality of combination of SGLT2i and DPP-4i | Dr. Rakesh Arora & Dr. Rohan Gupta

    Rationality of combination of SGLT2i and DPP-4i | Dr. Rakesh Arora & Dr. Rohan Gupta
    2023/02/10

    Listen to the Experts Discuss the Relevance of Rationality of the combination of SGLT2i and DPP-4i combinations.
    続きを読む 一部表示
    9 分
  • Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin | Dr. Mainak Banerjee & Dr. Debdatta Majumdar

    Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin | Dr. Mainak Banerjee & Dr. Debdatta Majumdar
    2022/11/02

    Listen to the Experts Discuss the Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin .
    続きを読む 一部表示
    15 分
  • Timely and optimal glycemic control with Empagliflozin and Linagliptin combination in T2DM management | Dr. Praveen Shankar & Dr. Ajoy Biswas

    Timely and optimal glycemic control with Empagliflozin and Linagliptin combination in T2DM management | Dr. Praveen Shankar & Dr. Ajoy Biswas
    2022/09/30

    Timely and optimal glycemic control with Empagliflozin and Linagliptin combination in T2DM management
    続きを読む 一部表示
    23 分
  • Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM management | Dr. Saurabh Mishra & Dr. Sachin Mishra

    Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM management | Dr. Saurabh Mishra & Dr. Sachin Mishra
    2022/08/06

    Listen to the Experts Discuss the Early initiation with Empagliflozin and Linagliptin combination for optimal glycemic control in T2DM management.
    続きを読む 一部表示
    14 分